<div id="readability-page-1"><div> <div> Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. , /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Organon &amp; Co. (NYSE: OGN)'s sale to Sun Pharmaceutical Industries Limited for $14.00 per share. If you are an Organon shareholder, click here to learn more about your legal rights and options. TruBridge, Inc. (NASDAQ: TBRG)'s sale to Inventurus Knowledge Solutions, Inc. for $26.25 in cash per share. If you are a TruBridge shareholder, click here to learn more about your rights and options. Cyclerion Therapeutics, Inc. (NASDAQ: CYCN)'s merger with Korsana Biosciences, Inc. Upon closing of the proposed transaction, Cyclerion shareholders are expected to own approximately 1.5% of the combined company. If you are a Cyclerion shareholder, click here to learn more about your legal rights and options. On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. One World Trade Center 85th Floor New York, NY 10007 (212) 763-0060 [email protected] [email protected] https://www.halpersadeh.com SOURCE Halper Sadeh LLP <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTA0Jk5ld3NJdGVtSWQ9Tlk1MDE3NyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MDQxNDU1UFJfTkVXU19VU1BSX19fX19OWTUwMTc3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTA0Jk5ld3NJdGVtSWQ9Tlk1MDE3NyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MDQxNDU1UFJfTkVXU19VU1BSX19fX19OWTUwMTc3"/></div> </div></div>

TBRG

CYCN

Halper Sadeh LLC is investigating Organon & Co. (NYSE: OGN), TruBridge, Inc. (NASDAQ: TBRG), and Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) for potential violations of federal securities laws and breaches of fiduciary duties. The firm is concerned that insiders may benefit financially at the expense of ordinary shareholders. Shareholders are encouraged to contact the firm for legal rights and options regarding the proposed transactions, which may limit competing offers. Halper Sadeh LLC operates on a contingent fee basis, ensuring no upfront costs for clients.

14:55 ETAre OGN, TBRG, CYCN Obtaining Fair Deals for their Shareholders?